Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
@article{Kaplan2011HyperactivationOM, title={Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells}, author={F. M. Kaplan and Y. Shao and M. M. Mayberry and A. Aplin}, journal={Oncogene}, year={2011}, volume={30}, pages={366-371} }
Activating mutations in B-RAF and N-RAS occur in ∼60 and ∼15% of melanomas, respectively. The most common mutation in B-RAF is V600E, which activates B-RAF and the downstream MEK–ERK1/2 pathway. Thus, B-RAFV600E is a viable therapeutic target. PLX4720 is a selective inhibitor of mutant B-RAF and its analog, PLX4032, is currently undergoing clinical trials in melanoma. However, the effects of PLX4720 across the genotypic spectrum in melanoma remain unclear. Here, we describe that PLX4720… CONTINUE READING
105 Citations
Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib‐resistant melanoma cells
- Biology, Medicine
- Pigment cell & melanoma research
- 2013
- 67
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- Biology, Medicine
- Clinical Cancer Research
- 2012
- 306
- PDF
SHOC2 and CRAF Mediate ERK1/2 Reactivation in Mutant NRAS-mediated Resistance to RAF Inhibitor*
- Biology, Medicine
- The Journal of Biological Chemistry
- 2012
- 46
- PDF
Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.
- Biology, Medicine
- Investigative ophthalmology & visual science
- 2011
- 47
- PDF
P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition.
- Biology, Medicine
- European journal of cancer
- 2017
- 27
- PDF
Inhibition of mutant BRAF splice variant signaling by next‐generation, selective RAF inhibitors
- Biology, Medicine
- Pigment cell & melanoma research
- 2014
- 32
Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.
- Biology, Medicine
- The American journal of pathology
- 2013
- 23
The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models
- Biology, Medicine
- PloS one
- 2011
- 18
- Highly Influenced
- PDF
References
SHOWING 1-10 OF 27 REFERENCES
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
- Biology, Medicine
- Pigment cell & melanoma research
- 2010
- 288
- Highly Influential
- PDF
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
- Biology, Medicine
- Cell
- 2004
- 2,254
- PDF
B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis
- Biology, Medicine
- Oncogene
- 2006
- 67
- PDF
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- Biology, Medicine
- Nature
- 2010
- 1,279
- PDF
Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
- Biology, Medicine
- Molecular Cancer Research
- 2009
- 114
- PDF
RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF
- Biology, Medicine
- Nature
- 2010
- 1,425
- PDF
Paradoxical activation of Raf by a novel Raf inhibitor.
- Biology, Medicine
- Chemistry & biology
- 1999
- 232
- PDF